Archives
-
Phosbind Biotin for Phosphorylation Detection
2026-09-19
Phosbind Biotin is a sequence-independent reagent for Western Blot detection of phosphorylated proteins on PVDF membranes. Its dinuclear metal complex phosphate binding chemistry connects membrane-based detection with protein phosphorylation analysis in signal transduction pathway research.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-18
Use dual fluorescence to separate mRNA uptake from functional translation in delivery screens, macrophage studies, and carrier optimization. This practical workflow combines Cy5-based tracking with EGFP expression to reveal where a formulation succeeds—or fails—in the delivery pathway.
-
Testosterone Bounce in Degarelix-Treated Prostate Cancer
2026-09-18
A 2024 retrospective study identified testosterone bounce, defined using a 20 ng/dL threshold, as a prognostic marker in prostate cancer patients receiving degarelix. The association with overall and cancer-specific survival suggests that serial testosterone kinetics may provide information beyond a single castration-level measurement, although the finding requires prospective validation.
-
Nanozymes Target Intramacrophage Bacteria in CRC
2026-09-17
The reference study develops a mannose-targeted, self-activatable polymeric nanozyme that combines ferrocene chemistry with artesunate to eliminate intracellular Fusobacterium nucleatum in colorectal cancer-associated macrophages. By reducing a bacterial driver of immunosuppression, the platform reprograms the macrophage ecosystem and improves the response to CD47 blockade in tumor models.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Assay Logic
2026-09-17
EZ Cap Cy5 Firefly Luciferase mRNA combines Cy5 tracking with Firefly Luciferase translation to separate cellular uptake, intracellular release, and protein expression. This guide presents a mechanistic assay framework for mRNA delivery and transfection, reporter interpretation, and in vivo study design.
-
ROS-Mediated Metabolic Rewiring in Melanoma
2026-09-16
Cesi et al. showed that BRAF or MEK inhibition increases reactive oxygen species, activates pyruvate dehydrogenase kinases, and suppresses PDH-dependent oxidative metabolism in melanoma cells. The work identifies PDK inhibition as a potential metabolic vulnerability in BRAF-mutant and BRAF inhibitor-resistant melanoma, while also clarifying how treatment-induced stress can reshape tumor-cell growth.
-
Regorafenib: From Kinase Breadth to RRM2
2026-09-16
Regorafenib is more than a broad-spectrum kinase tool. Emerging melanoma data connect its multikinase activity with RRM2 suppression and ERK/E2F3 modulation, creating a practical framework for mechanism-led cancer biology research and translational study design.
-
VX-661: A Mechanism-First CFTR Assay Framework
2026-09-15
VX-661, a F508del CFTR corrector, is best evaluated by separating CFTR folding, surface delivery, and channel function. This mechanism-first guide translates calnexin-dependent variant research into practical assay design and interpretation for cystic fibrosis research.
-
Resazurin sodium salt: Practical Cell Assay Guide
2026-09-15
Build more reliable metabolic, proliferation, and cytotoxicity workflows with Resazurin sodium salt while controlling solvent, exposure time, and redox-related artifacts. The guide translates glutamine-metabolism findings in hepatic stellate cells into practical assay design without confusing metabolic signal with direct cell counting or pathway flux.
-
A-1210477: MCL-1 Inhibitor Research Guide
2026-09-14
A-1210477 is a potent, selective MCL-1 inhibitor for mechanistic cancer research. It disrupts MCL-1–BIM signaling and supports apoptosis studies in MCL-1-dependent cells, but its reported pharmacokinetic limitations restrict direct in vivo interpretation.
-
Artificial Photoreceptors with Biomimetic Adaptation
2026-09-14
Zhang and colleagues developed a ferroelectric-liquid metal hybrid film that converts visible and near-infrared light into bioelectrical signals while reproducing scotopic and photopic adaptation without external circuitry. In retinal-degeneration models, the implant restored visible-light sensitivity, enabled infrared perception, and remained integrated and biocompatible for three months, supporting further development of flexible retinal prostheses.
-
EZ Cap EGFP mRNA 5-moUTP Workflow Guide
2026-09-13
Learn how to use EZ Cap EGFP mRNA 5-moUTP as a stable fluorescent reporter for delivery, translation, viability, and imaging studies. The workflow also translates machine-learning-guided lipid nanoparticle findings into practical assay design and troubleshooting decisions.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-09-12
Zhang et al. show that CDC42-dependent epithelial polarity controls the intestinal stem cell-to-transit-amplifying cell transition through a YAP/TAZ–epiregulin–mTOR axis that operates independently of canonical Wnt signaling. The study connects epithelial architecture to crypt proliferation and provides a genetic and pharmacological framework for dissecting intestinal renewal mechanisms.
-
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-09-11
The 2024 Cell Death & Differentiation study identifies ASB3 as an E3 ubiquitin ligase that suppresses antiviral innate immunity by directing K48-linked ubiquitination and proteasomal degradation of MAVS. Its genetic, biochemical, infection, and animal-model evidence connects ASB3 activity to reduced type I interferon signaling and increased susceptibility to influenza A virus.
-
Pseudo-UTP: From RNA Chemistry to Translation
2026-09-11
Pseudo-modified uridine triphosphate is more than a UTP substitute: it is a design variable connecting RNA chemistry with translation, innate immune sensing, and translational performance. This thought-leadership article explains the mechanistic rationale for Pseudo-UTP, interprets preclinical mRNA vaccine evidence without overclaiming, and offers practical guidance for researchers evaluating RNA stability enhancement, mRNA vaccine development, and gene therapy RNA modification.